← Evidence map

ArticleBioFactors (Oxford, England)

Fisetin is a selective adenosine triphosphate-competitive inhibitor for mitogen-activated protein kinase kinase 4 to inhibit lipopolysaccharide-stimulated inflammation.

Ziyu He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
2026
pooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39087587